These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8542262)
1. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. Short AK; Lockwood CM QJM; 1995 Nov; 88(11):775-83. PubMed ID: 8542262 [TBL] [Abstract][Full Text] [Related]
2. Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review. Dobre M; Wish J; Negrea L Ren Fail; 2009; 31(8):745-8. PubMed ID: 19814644 [TBL] [Abstract][Full Text] [Related]
3. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity. Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101 [TBL] [Abstract][Full Text] [Related]
4. Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis. Yokogawa N; Vivino FB Mod Rheumatol; 2009; 19(3):338-47. PubMed ID: 19424772 [TBL] [Abstract][Full Text] [Related]
5. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976 [TBL] [Abstract][Full Text] [Related]
6. ANCA associated vasculitis allergica cutis (VAC) and mild proliferative necrotizing glomerulonephritis. Nakabayashi I; Yoshizawa N; Kubota T; Akashi Y; Nishiyama J; Suzuki Y; Oshima S; Oda T; Niwa H; Yoshida M Clin Nephrol; 1993 Nov; 40(5):265-9. PubMed ID: 8281715 [TBL] [Abstract][Full Text] [Related]
7. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis. Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935 [TBL] [Abstract][Full Text] [Related]
8. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis]. Ara J; Mirapeix E; Rodríguez R; Pascual J; Alvarez L; Darnell A Med Clin (Barc); 1998 Oct; 111(14):536-8. PubMed ID: 9859079 [TBL] [Abstract][Full Text] [Related]
9. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis. Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705 [TBL] [Abstract][Full Text] [Related]
10. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. Pradhan VD; Badakere SS; Bichile LS; Almeida AF J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975 [TBL] [Abstract][Full Text] [Related]
11. Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis. Kumar B; Strouse J; Swee M; Lenert P; Suneja M Semin Arthritis Rheum; 2018 Oct; 48(2):283-287. PubMed ID: 29519741 [TBL] [Abstract][Full Text] [Related]
12. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Choi HK; Merkel PA; Walker AM; Niles JL Arthritis Rheum; 2000 Feb; 43(2):405-13. PubMed ID: 10693882 [TBL] [Abstract][Full Text] [Related]
13. Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients. Arranz O; Ara J; Rodriguez R; Quintó L; Font J; Mirapeix E; Darnell A Clin Nephrol; 2001 Oct; 56(4):295-301. PubMed ID: 11680659 [TBL] [Abstract][Full Text] [Related]
14. Antineutrophil cytoplasmic autoantibodies in patients with systemic lupus erythematosus recognize a novel 69 kDa target antigen of neutrophil granules. Chen M; Zhao MH; Zhang YK; Wang HY Nephrology (Carlton); 2005 Oct; 10(5):491-5. PubMed ID: 16221101 [TBL] [Abstract][Full Text] [Related]
15. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis. Nachman PH; Reisner HM; Yang JJ; Jennette JC; Falk RJ Lab Invest; 1996 Feb; 74(2):519-27. PubMed ID: 8780169 [TBL] [Abstract][Full Text] [Related]
16. [Antineutrophil cytoplasmic antibodies (ANCA): clinico-pathologic correlations iin a series of 82 cases]. Calvo Romero JM; Romero Requena J; Arévalo Lorido JC; Ramos Salado JL; Doblaré Castellano E; Vargas Pérez ML; Bureo Dacal P; Pérez Miranda M An Med Interna; 2002 Jan; 19(1):7-10. PubMed ID: 11989089 [TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases. Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953 [TBL] [Abstract][Full Text] [Related]
18. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides. Sinclair D; Stevens JM Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028 [TBL] [Abstract][Full Text] [Related]
19. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. Gao Y; Ye H; Yu F; Guo XH; Zhao MH Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262 [TBL] [Abstract][Full Text] [Related]
20. Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis. Ardiles LG; Valderrama G; Moya P; Mezzano SA Clin Nephrol; 1997 Jan; 47(1):1-5. PubMed ID: 9021233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]